News About: Goverment
Prescription Refill System, Substitution Dispensary Practice Suggested
After over four years since the implementation of pharmaceutical regulation that has separated dispensary from medical practices, Rep. Chang Bok-shim of the ruling Uri Party recommended a number of follow-up measures ...
Foreign Trade Information Repository Now Established
The Korea Health Industry Development Institute (KHIDI) announced this week of an establishment of international trade information repository, detailing the import and export trade activities by eight specific foreign...
Total Number of Bioequivalent Drugs at 2,555
The Korea Food and Drug Administration (KFDA) recently released information on the list of approved bioequivalent drugs that has been compiled through the end of last year, with relevant analysis conducted on a total ...
KFDA Establishes Guidance for Combination Products
Reflective of ongoing technological and scientific advances that merge various therapeutic agents into multi-purpose combination products, the Korea Food and Drug Administration (KFDA) announced on February 15th that ...
KFDA Releases Advisory Statement on Methotrexate
The Korea Food and Drug Administration (KFDA) released an advisory statement on February 14th to the healthcare professionals and pharmacists on the reported mortality instances in Japan by medications containing meth...
KFDA Undertakes Initial Reviews on KGMP Certified Companies
The Korea Food and Drug Administration (KFDA) announced last week that it plans to undertake an initial evaluation review on the KGMP (Korea Good Manufacturing Practice) certified companies during this year, in order ...
81 Products from 5 Active Ingredient Categories Receive Revised Market Specifications
The Korea Food and Drug Administration (KFDA) recently announced that a total of 81 pharmaceutical products from 5 active ingredient categories have been issued the revised post-marketing approval specifications.
T...
KFDA Conducts Intense Inspection on Medications with High Safety and Health Risks
The Korea Food and Drug Administration (KFDA) recently announced an intensive inspection effort on the current practices surrounding the proper distribution and availability of medications that are subject to potentia...
Advanced Funding of 71.5 Billion Won to Support Key R&D Projects
The Korea Health Industry Development Institute (KHIDI) announced that it will make an advanced funding support of 71.5 billion won to promote an active undertaking of strategic research and development initiatives on...
KFDA Launches On-line Education Service on Drug Approval Requests
The Korea Food and Drug Administration (KFDA) announced an official introduction of the on-line education program service geared to provide an effective guidance on the drug approval request submissions.
From the...
